Altre lingue BBS-Bioactive Bone Substitutes Oyj

Azioni

BONEH

FI4000260583

Tempo differito Nasdaq Helsinki Altri mercati azionari 18:00:00 25/06/2024			Variaz. 5gg	Var. 1 gen.
0,35 ^EUR	+4,48%		+14,01%	-28,43%

13/06	BBS-Bioactive Bone Substitutes Oyj approva l'elezione di Gregor Siebert come nuovo membro del Consiglio di Amministrazione	CI
04/06	BBS-Bioactive Bone Substitutes Plc annuncia l'approvazione della domanda di brevetto complementare per il prodotto ARTEBONE®.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi	19/06
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy	18/06
BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report	18/06
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy	14/06
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024	13/06
BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors	13/06
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	05/06
BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA	04/06
BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product	04/06
Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting	23/05
BBS-Bioactive Bone Substitutes Plc Announces Ahti Paananen Not Available for Re-Election to the Board of Directors	23/05
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	21/05
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	07/05
BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process	05/05
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc	25/04
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	24/04
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	17/04
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	15/04
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored	05/04
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	03/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BBS-Bioactive Bone Substitutes Oyj

Azioni

BONEH

FI4000260583

Altre lingue

Filtri